Institut für Hygiene und Mikrobiologie

Curriculum vitae Prof. Dr. med. Oliver Kurzai

Academic Education
1994-2001 Studies at University of Würzburg, Medical School; State Exam, Approbation
Advanced Professional Degrees
2008 Habilitation „Medical Microbiology“
2006 Medical Specialist Recognition (Facharzt) Microbiology, Virology and Infection Epidemiology
2002 Doctoral Thesis Dr. med. (summa cum laude)
Positions held
Since 2021 Head of Institute for Hygiene and Microbiology, Univ. of Würzburg  
Since 2017 Professor and Chair “Medical Microbiology and Mycology”, Univ. of Würzburg 
Since 2017 Affiliated Researcher and Research Group Leader, Leibniz Institute for Natural Product Research and Infection Biology – Hans-Knoell-Institute (HKI), Jena
2009-2016 Professor for Fungal Septomics, Friedrich-Schiller-University Jena and Leibniz Institute for Natural Product Research and Infection Biology, HKI, Jena
2001-2009 M.D. / Lecturer, Institute for Hygiene and Microbiology, Univ. of Würzburg
Professional Activities
Since 2018 Member and Vice Speaker, Executive Board, Center for Infectious Diseases Research, Würzburg, Germany
Since 2015 National Delegate, Antifungal Susceptibility Testing Subcommittee, EUCAST
Since 2014 Head, German National Reference Center for Invasive Fungal Infections (NRZMyk)
Since 2013 Scientific Administrator, InfectControl 2020
Since 2012 Editor-in-Chief, Medical Mycology Case Reports, Member (ex officio) executive board International Society for Human & Animal Mycology (ISHAM)
Since 2011 Elected Secretary of the Deutschsprachige Mykologische Gesellschaft (DMykG)
2014-2016 Speaker, Septomics Research Center, Jena
2013-2015 Member, Executive Board, Center for Sepsis Control and Care, Jena
Stipends and Awards
2008 Career Award, German Society for Hygiene and Microbiology
2002 Becton-Dickinson Dissertation Awards of the German Society for Hygiene and Microbiology
Selected Publications 
  • Geißel B et al. (2018) Azole-induced cell wall carbohydrate patches kill Aspergillus fumigatus. Nat Commun 9: 3098.
  • Cunha C et al. (2017) IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity. J Allergy Clin Immunol 140: 867-870.
  • Moyes DL et al. (2016) Candidalysin is a fungal peptide toxin critical for muco-sal infection. Nature 532: 64-68.
  • Linde J et al. (2015) Defining the transcriptomic landscape of Candida glabrata by RNA-Seq. Nucleic Acids Res 43: 1392-1406.
  • Cunha C et al. (2014) Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation.N Engl J Med 370: 421-432.